Skip to main content Accessibility help

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

  • Kathryn A Ellis (a1) (a2) (a3), Ashley I Bush (a2) (a4), David Darby (a5) (a6), Daniela De Fazio (a2), Jonathan Foster (a7) (a8) (a9), Peter Hudson (a10), Nicola T. Lautenschlager (a1) (a11), Nat Lenzo (a7) (a8), Ralph N. Martins (a7) (a8), Paul Maruff (a5) (a6), Colin Masters (a2) (a6), Andrew Milner (a12), Kerryn Pike (a2) (a13), Christopher Rowe (a13), Greg Savage (a14), Cassandra Szoeke (a10) (a3), Kevin Taddei (a7) (a8), Victor Villemagne (a13), Michael Woodward (a13), David Ames (a1) (a3) and the AIBL Research Group (a15)...


Background: The Australian Imaging, Biomarkers and Lifestyle (AIBL) flagship study of aging aimed to recruit 1000 individuals aged over 60 to assist with prospective research into Alzheimer's disease (AD). This paper describes the recruitment of the cohort and gives information about the study methodology, baseline demography, diagnoses, medical comorbidities, medication use, and cognitive function of the participants.

Methods: Volunteers underwent a screening interview, had comprehensive cognitive testing, gave 80 ml of blood, and completed health and lifestyle questionnaires. One quarter of the sample also underwent amyloid PET brain imaging with Pittsburgh compound B (PiB PET) and MRI brain imaging, and a subgroup of 10% had ActiGraph activity monitoring and body composition scanning.

Results: A total of 1166 volunteers were recruited, 54 of whom were excluded from further study due to comorbid disorders which could affect cognition or because of withdrawal of consent. Participants with AD (211) had neuropsychological profiles which were consistent with AD, and were more impaired than participants with mild cognitive impairment (133) or healthy controls (768), who performed within expected norms for age on neuropsychological testing. PiB PET scans were performed on 287 participants, 100 had DEXA scans and 91 participated in ActiGraph monitoring.

Conclusion: The participants comprising the AIBL cohort represent a group of highly motivated and well-characterized individuals who represent a unique resource for the study of AD. They will be reassessed at 18-month intervals in order to determine the predictive utility of various biomarkers, cognitive parameters and lifestyle factors as indicators of AD, and as predictors of future cognitive decline.


Corresponding author

Correspondence should be addressed to: Kathryn A. Ellis, Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne, St. Vincent's Aged Psychiatry Service, St George's Hospital Campus, 283 Cotham Rd, Kew, Victoria 3101, Australia. Phone: +61 3 9389 2919; Fax +61 3 9816 0477. Email:


Hide All
Access Economics (2005). Dementia Estimates and Projections, Australian States and Territories. Canberra: Alzheimer's Australia.
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
Brink, T. L., Yesavage, J. A., Lum, O., Heersema, P., Adey, M. B. and Rose, T. L. (1982). Screening tests for geriatric depression. Clinical Gerontologist, 1, 3744.
Corballis, M. C. (2009). The evolution and genetics of cerebral asymmetry. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 364, 867879.
Corbo, R. M. and Scacchi, R. (1999). Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? Annals of Human Genetics, 63, 301310.
Craig, C. L. et al. (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise, 35, 13811395.
Delis, D., Kramer, J., Kaplan, E. and Ober, B. (2000). California Verbal Learning Test-Second Edition. San Antonio, TX: The Psychological Corporation.
Delis, D. C., Kaplan, E. and Kramer, J. H. (2001). The Delis-Kaplan Executive Function System (D-KEFS). San Antonio TX: Psychological Corporation.
Ferri, C. P. et al. (2005). Global prevalence of dementia: a Delphi consensus study. Lancet, 366, 21122117.
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.
Glodzik-Sobanska, L. et al. (2007). Subjective memory complaints: presence, severity and future outcome in normal older subjects. Dementia and Geriatric Cognitive Disorders, 24, 177184.
Hodge, A., Patterson, A. J., Brown, W. J., Ireland, P. and Giles, G. (2000). The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Australian and New Zealand Journal of Public Health, 24, 576583.
Jonker, C., Geerlings, M. I. and Schmand, B. (2000). Are memory complaints predictive for dementia? A review of clinical and population-based studies. International Journal of Geriatric Psychiatry, 15, 983991.
Jorm, A. F. and Jacomb, P. A. (1989). The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychological Medicine, 19, 10151022.
Jost, B. C. and Grossberg, G. T. (1996). The evolution of psychiatric symptoms in Alzheimer's disease: a natural history study. Journal of the American Geriatrics Society, 44, 10781081.
Kryscio, R. J., Schmitt, F. A., Salazar, J. C., Mendiondo, M. S. and Markesbery, W. R. (2006). Risk factors for transitions from normal to mild cognitive impairment and dementia. Neurology, 66, 828832.
Larrieu, S. et al. (2002). Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology, 59, 15941599.
Lautenschlager, N. T. et al. (2008). Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA, 300, 10271037.
Lyketsos, C. G. and Olin, J. (2002). Depression in Alzheimer's disease: overview and treatment. Biological Psychiatry, 52, 243252.
Martins, R. N. et al. (1995). ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome. Neuroreport, 6, 15131516.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939944.
Mega, M. S., Cummings, J. L., Fiorello, T. and Gornbein, J. (1996). The spectrum of behavioral changes in Alzheimer's disease. Neurology, 46, 130135.
Meyers, J. E. and Meyers, K. R. (1995). Rey Complex Figure Test and Recognition Trial.Professional Manual: Psychological Assessment Resource, Inc.
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 24122414.
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303308.
Pike, K. E. et al. (2007). Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain, 130, 28372844.
R Development Core Team (2005). R: A Language and Environment for Statistical Computing, reference index version 2.8.1. Vienna: R Foundation for Statistical Computing.
Reisberg, B. (2007). Global measures: utility in defining and measuring treatment response in dementia. International Psychogeriatrics, 19, 421456.
Reisberg, B. and Gauthier, S. (2008). Current evidence for subjective cognitive impairment (SCI) as the pre-mild cognitive impairment (MCI) stage of subsequently manifest Alzheimer's disease. International Psychogeriatrics, 20, 116.
Ritchie, C. W., Ames, D., Masters, C. L. and Cummings, J. (2007). Therapeutic Strategies in Dementia. Oxford: Clinical Publishing.
Rozzini, R., Gozzoli, M. P., Indelicato, A., Lonati, F. and Trabucchi, M. (2008). Patterns of antidepressants prescriptions in a large Italian old population. International Journal of Geriatric Psychiatry, 23, 872873.
Rowe, C. C. et al. (2007). Imaging beta-amyloid burden in aging and dementia. Neurology, 68, 17181725.
Saxton, J. et al. (2000). Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clinical Neuropsychology, 14, 526534.
Sheikh, J. I. and Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In Brink, T. L. (ed.), Clinical Gerontology: A Guide to Assessment and Intervention (pp. 165173). New York: The Haworth Press.
Snaith, R. P. and Zigmond, A. S. (1986). The hospital anxiety and depression scale. British Medical Journal, 292, 344.
Solfrizzi, V. et al. (2004). Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology, 63, 18821891.
Strauss, E., Sherman, and Spreen, O. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary (3rd edn). New York: Oxford University Press.
Takeda, M., Okochi, M., Tagami, S., Tanaka, T. and Kudo, T. (2007). Biological markers as outcome measures for Alzheimer's disease interventions – real problems and future possibilities. International Psychogeriatrics, 19, 391400.
Wechsler, D. (1945). A standardised memory scale for clinical use. Journal of Psychology, 19, 8795.
Wechsler, D. (1997). Wechsler Adult Intelligence Scale, 3rd edn(WAIS-III). San Antonio, TX: Psychological Corporation.
Wechsler, D. (2001). Wechsler Test of Adult Reading: Examiner's Manual. San Antonio, TX: The Psychological Corporation.
Winblad, B. et al. (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240246.
World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
Yesavage, J. A. et al. (1982). Development and validation of a geriatric depression screening scale: a preliminary report. Journal of Psychiatric Research, 17, 3749.
Zigmond, A. S. and Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361370.


The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

  • Kathryn A Ellis (a1) (a2) (a3), Ashley I Bush (a2) (a4), David Darby (a5) (a6), Daniela De Fazio (a2), Jonathan Foster (a7) (a8) (a9), Peter Hudson (a10), Nicola T. Lautenschlager (a1) (a11), Nat Lenzo (a7) (a8), Ralph N. Martins (a7) (a8), Paul Maruff (a5) (a6), Colin Masters (a2) (a6), Andrew Milner (a12), Kerryn Pike (a2) (a13), Christopher Rowe (a13), Greg Savage (a14), Cassandra Szoeke (a10) (a3), Kevin Taddei (a7) (a8), Victor Villemagne (a13), Michael Woodward (a13), David Ames (a1) (a3) and the AIBL Research Group (a15)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed